Rights and permissions
About this article
Cite this article
Lilly’s educational schizophrenia programme shows promise. Pharmacoecon. Outcomes News 136, 11 (1997). https://doi.org/10.1007/BF03272160
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03272160